A carregar...
Disclosure of preclinical Alzheimer's disease biomarker results in research and clinical settings: Why, how, and what we still need to know
Disclosure of personal disease‐related information to asymptomatic adults has been debated over the last century in medicine and research. Recently, Alzheimer's disease (AD) has been conceptualized as a continuum that begins with a “preclinical” stage in which biomarkers are present in the abse...
Na minha lista:
| Publicado no: | Alzheimers Dement (Amst) |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7896633/ https://ncbi.nlm.nih.gov/pubmed/33665341 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/dad2.12150 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|